Aimmune Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
Nestle Acquires Aimmune For $34.50 Per Share In Cash Or $2.6B
Article By: The Fly
Monday, August 31, 2020 8:14 AM EDT
Aimmune Therapeutics announced that it has entered into a definitive agreement for Societes des Produits Nestle to acquire Aimmune for $34.50 per share in an all-cash transaction, implying a fully-diluted equity value of $2.6B.
In this article: NSRGY, AIMT
Read
Aimmune Shares Can Trade Into The $60 Range, Says Piper Sandler
Article By: The Fly
Monday, February 3, 2020 7:45 AM EDT
Piper Sandler analyst Christopher Raymond says he continues to believe shares of Aimmune Therapeutics can trade into the $60 range following Friday's FDA approval of peanut allergy treatment Palforzia.
In this article: AIMT
Read
Stock Charts To Watch - Tuesday, Jan. 14
Article By: Harry Boxer
Tuesday, January 14, 2020 10:27 PM EDT
Aimmune Therapeutics, Inc. has had a beautiful uptrend since it spiked in Sept, pulled back in a falling wedge, popped out of the wedge and ran up to the resistance level, formed another falling wedge, and then ran five waves up.
In this article: RAD, HALO, IRIX, AGTC, AIMT, DNLI
Read
Week In Review: How Trump's Policies Moved Stocks - Jan. 20
Article By: The Fly
Sunday, January 20, 2019 11:34 PM EDT
Companies begin to see impact from shutdown, Grassley sees Trump proceeding with tariffs on imported cars
In this article: AUGCAUG, AXL, BWA, CMRE, DAC, DLPH, F, GM, HMC, KBH, LEA, LEN, MGA, NM, PHM, TEN, TGH, TM, VC, ADNT, NSANY, VLKAY, DCIX, Z, BIIB, CELG, EXPD, FCAU, ZG, RLGY, AIMT, RDFN, APTV
Read
10 Hot Small Caps Primed For A Winning Streak (Part II)
Article By: TipRanks
Wednesday, July 4, 2018 8:43 AM EDT
Small cap stocks are looking very attractive right now. Year-to-date the Russell 2000 small-cap index is up over 8%.
In this article: IMPV, CONN, TXMD, AIMT, RCM
Read

Latest Tweets for $AIMT

No tweets yet!

PARTNER HEADLINES

$AIMT

Will Chamath Finally Do A Deal For His IPOF SPAC? (19 Months Later)
Michael Levin 6/6/2022 10:03:46 PM

Remember, Grand Slams also come with strikeouts with the bases loaded. For me to list them all would be to tout that this one will be one of them. That said, for the helluvit the one I loved the most was $AIMT. They had a peanut allergy drug that the FDA approved and the stock was around $31-35 the day it happened. Nestle stepped up and bought 20% of the Co. for $31 in early 2020. Covid hit and many stocks got crushed and stayed there. Later in August the EU put out a report on how good the drug was as well as earlier in the Summer the FDA struck down a competitors drug attempt at peanut allergies. I said to myself "Here is $AIMT at $12.90 (Fri Aug 28th) and with no more potential competition as well as EU "loving" this drug, Nestle has got to step up and buy the rest of this Co." and I bought the Sep $15 calls for $.25  That Monday Nestle bought them out for $32.40 or so and I sold those calls for $19.10 roughly 71:1 payoff. I was shocked that I bought these calls on a Fri on a whim and the next trading day $AIMT was the #1 stock in the world for % gain. True story. I have MANY stories of the opposite as well, where I lost All, so these things do NOT happen often.  Best of luck.

Will Chamath Finally Do A Deal For His IPOF SPAC? (19 Months Later)
Walken Talken 6/3/2022 6:16:47 PM

Remember, Grand Slams also come with strikeouts with the bases loaded. For me to list them all would be to tout that this one will be one of them. That said, for the helluvit the one I loved the most was $AIMT. They had a peanut allergy drug that the FDA approved and the stock was around $31-35 the day it happened. Nestle stepped up and bought 20% of the Co. for $31 in early 2020. Covid hit and many stocks got crushed and stayed there. Later in August the EU put out a report on how good the drug was as well as earlier in the Summer the FDA struck down a competitors drug attempt at peanut allergies. I said to myself "Here is $AIMT at $12.90 (Fri Aug 28th) and with no more potential competition as well as EU "loving" this drug, Nestle has got to step up and buy the rest of this Co." and I bought the Sep $15 calls for $.25  That Monday Nestle bought them out for $32.40 or so and I sold those calls for $19.10 roughly 71:1 payoff  I was shocked that I bought these calls on a Fri on a whim and the next trading day $AIMT was the #1 stock in the world for % gain. True story. I have MANY stories of the opposite as well, where I lost All, so these things do NOT happen often.  Best of luck

1 to 2 of 2 comments